Global Anti-Malarial Drug Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Anti-Malarial Drug market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Anti-Malarial Drug market."
Anti-malarial drugs (also called anti-malarials) are medications used for the treatment and prevention of malaria infection.
On the one hand, they are used for routine intermittent treatment of specific groups in endemic regions. On the other, the drug can prevent the infection in individuals who travel or visit a malaria-endemic region

The global Anti-Malarial Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Malarial Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Malarial Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    GlaxoSmithKline
    Ranbaxy
    Zydus Cadila
    Alvizia
    Bayer
    Ipca
    Merck
    F. Hoffmann-La Roche
    Novartis
    Pfizer

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    By meterial
        Plasmodium Falciparum
        Plasmodium Vivax
        Plasmodium Malariae
        Plasmodium Ovale
    By mechanism of action
        Resistance
        Prevention

Segment by Application
    Hospital Pharmacy
    Retail Pharmacy
    E-Commerce
    Others